BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30045946)

  • 21. The role of ThPOK in control of CD4/CD8 lineage commitment.
    He X; Park K; Kappes DJ
    Annu Rev Immunol; 2010; 28():295-320. PubMed ID: 20307210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling.
    Luckey MA; Kimura MY; Waickman AT; Feigenbaum L; Singer A; Park JH
    Nat Immunol; 2014 Jul; 15(7):638-45. PubMed ID: 24880459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p300-mediated acetylation stabilizes the Th-inducing POK factor.
    Zhang M; Zhang J; Rui J; Liu X
    J Immunol; 2010 Oct; 185(7):3960-9. PubMed ID: 20810990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SRSF1 Deficiency Impairs the Late Thymocyte Maturation and the CD8 Single-Positive Lineage Fate Decision.
    Ji C; Bao L; Yuan S; Qi Z; Wang F; You M; Yu G; Liu J; Cui X; Wang Z; Liu J; Guo W; Feng M; Chen F; Kang Y; Yu S
    Front Immunol; 2022; 13():838719. PubMed ID: 35154164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ThPOK transcription factor differentially affects the development and function of self-specific CD8(+) T cells and regulatory CD4(+) T cells.
    Twu YC; Teh HS
    Immunology; 2014 Mar; 141(3):431-45. PubMed ID: 24708418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional and epigenetic regulation of CD4/CD8 lineage choice.
    Taniuchi I; Ellmeier W
    Adv Immunol; 2011; 110():71-110. PubMed ID: 21762816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lineage re-commitment of CD4CD8αα intraepithelial lymphocytes in the gut.
    Park Y; Moon SJ; Lee SW
    BMB Rep; 2016 Jan; 49(1):11-7. PubMed ID: 26592937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transcription factor Zbtb7b promotes CD4 expression by antagonizing Runx-mediated activation of the CD4 silencer.
    Wildt KF; Sun G; Grueter B; Fischer M; Zamisch M; Ehlers M; Bosselut R
    J Immunol; 2007 Oct; 179(7):4405-14. PubMed ID: 17878336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4+ T cells.
    Vacchio MS; Wang L; Bouladoux N; Carpenter AC; Xiong Y; Williams LC; Wohlfert E; Song KD; Belkaid Y; Love PE; Bosselut R
    Nat Immunol; 2014 Oct; 15(10):947-56. PubMed ID: 25129370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
    Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
    Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation.
    Jenkinson SR; Intlekofer AM; Sun G; Feigenbaum L; Reiner SL; Bosselut R
    J Exp Med; 2007 Feb; 204(2):267-72. PubMed ID: 17296789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coreceptor signal strength regulates positive selection but does not determine CD4/CD8 lineage choice in a physiologic in vivo model.
    Erman B; Alag AS; Dahle O; van Laethem F; Sarafova SD; Guinter TI; Sharrow SO; Grinberg A; Love PE; Singer A
    J Immunol; 2006 Nov; 177(10):6613-25. PubMed ID: 17082573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Runx-dependent and silencer-independent repression of a maturation enhancer in the Cd4 gene.
    Kojo S; Yasmin N; Muroi S; Tenno M; Taniuchi I
    Nat Commun; 2018 Sep; 9(1):3593. PubMed ID: 30185787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(+) T cells.
    Wang L; Wildt KF; Zhu J; Zhang X; Feigenbaum L; Tessarollo L; Paul WE; Fowlkes BJ; Bosselut R
    Nat Immunol; 2008 Oct; 9(10):1122-30. PubMed ID: 18776904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.
    He X; He X; Dave VP; Zhang Y; Hua X; Nicolas E; Xu W; Roe BA; Kappes DJ
    Nature; 2005 Feb; 433(7028):826-33. PubMed ID: 15729333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the expression of cKrox and Runx3, transcription regulatory factors controlling the lineage commitment of CD4+CD8+ into CD4 and CD8 thymocytes, respectively.
    Gill BC; Jeon CH; Sung HN; Kim HL; Jin DW; Park JH
    Toxicol Lett; 2008 Aug; 180(3):189-95. PubMed ID: 18602973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision.
    Sato T; Chiba T; Ohno S; Sato C; Sugoh T; Miyashita K; Akatsuka H; Hozumi K; Okada Y; Iida Y; Akatsuka A; Agata Y; Chiba M; Kohu K; Satake M; Tanabe H; Saya H; Habu S
    J Immunol; 2012 Nov; 189(9):4426-36. PubMed ID: 23018457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis.
    Woolf E; Xiao C; Fainaru O; Lotem J; Rosen D; Negreanu V; Bernstein Y; Goldenberg D; Brenner O; Berke G; Levanon D; Groner Y
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7731-6. PubMed ID: 12796513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The enigma of CD4-lineage specification.
    Xiong Y; Bosselut R
    Eur J Immunol; 2011 Mar; 41(3):568-74. PubMed ID: 21341258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCR7 expression in developing thymocytes is linked to the CD4 versus CD8 lineage decision.
    Yin X; Ladi E; Chan SW; Li O; Killeen N; Kappes DJ; Robey EA
    J Immunol; 2007 Dec; 179(11):7358-64. PubMed ID: 18025179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.